XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Stock-Based Compensation  
Stock-Based Compensation

7. Stock-Based Compensation

Summary of Stock Option and Award Activity

The following table summarizes the stock option and award activity for the three months ended March 31, 2024:

Options Outstanding

Weighted-

Weighted-

Options and

Average

Average

Aggregate

Awards

Exercise

Remaining

Intrinsic

Available for

Number of

Price Per

Contractual

Value

Grant

    

Options

    

Share

    

Life (years)

    

(In thousands)

Balance—December 31, 2023

 

598,397

1,829,428

$

5.96

6.9

$

5,676

Authorized

 

632,414

RSUs granted

(854,927)

RSUs cancelled/forfeited

Warrants exercised

Options granted

$

Options exercised

 

(96,116)

$

3.67

$

470

Options cancelled/forfeited

 

$

Balance—March 31, 2024

 

375,884

 

1,733,312

$

6.09

6.7

$

3,405

Options exercisable—March 31, 2024

 

 

1,304,017

$

5.80

6.4

$

2,935

The total grant date fair value of options vested was $0.3 million and $1.9 million during the three months ended March 31, 2024 and 2023, respectively. There were no options granted during the three months ended March 31, 2024. The weighted-average grant date fair value of options granted during the three months ended March 31, 2023 was $3.20 per share.

As of March 31, 2024, there was $1.9 million of total unrecognized stock-based compensation expense related to unvested options which is expected to be recognized over a weighted-average period of 1.5 years. Stock-based compensation cost for options capitalized within inventory at March 31, 2024 and 2023 was not material.

2016 Employee Stock Purchase Plan

In January 2024, there was an increase of 210,804 shares reserved for issuance under the Company’s Employee Stock Purchase Plan (ESPP) pursuant to the terms of the ESPP. The Company had 1,100,966 shares available for future issuance under the Company’s ESPP as of March 31, 2024. Employees did not purchase any shares during the three months ended March 31, 2024 and 2023, respectively.

Restricted Stock Units

The following table summarizes restricted stock units (RSUs) activity for the three months ended March 31, 2024:

RSUs Outstanding

    

Weighted-

    

Average

Number of

    

Grant Date

Restricted Stock

    

Fair Value Per

    

Units

    

Share

Balance—December 31, 2023

905,781

$

6.59

Granted

 

854,927

$

8.93

Vested

(229,923)

$

6.43

Cancelled/forfeited

$

Balance—March 31, 2024

 

1,530,785

    

$

7.92

The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date.

As of March 31, 2024, there was $10.9 million of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 2.8 years. Stock-based compensation cost related to RSUs capitalized within inventory at March 31, 2024 and 2023 was not material.